Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects (Q42177743)

From Wikidata
Jump to navigation Jump to search
scientific article published on 3 December 2014
edit
Language Label Description Also known as
English
Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects
scientific article published on 3 December 2014

    Statements

    Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects (English)
    Matt S Anderson
    Jocelyn Gilmartin
    Caroline Cilissen
    Inge De Lepeleire
    Luc Van Bortel
    Marissa F Dockendorf
    Ernestina Tetteh
    June K Ancona
    Rachael Liu
    Ying Guo
    John A Wagner
    Joan R Butterton
    3 December 2014
    397-405

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit